Searched for
CLINICAL TESTING ON ANIMALS
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...- Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
- What to know about the outbreak of a rare kind of Ebola as cases outpace responseA rare Ebola outbreak is spreading rapidly in Congo and Uganda. The Bundibugyo virus has no approved treatments. Health workers face challe...
- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
- Hantavirus scientists were close to vaccine but ran out of moneyScientists in Chile developed antibodies that successfully neutralised the deadly Andes hantavirus in lab and animal studies, raising hopes...
- The ugliest animal on Earth may be humanity's best hope for living longer — here's the scienceNaked mole rats, known for their longevity and cancer resistance, possess high levels of a protective molecule called HMW-HA. Researchers s...
- Scientists just found the holy grail gene that could let humans regrow their own limbs one dayScientists studying naked mole rats discovered a gene linked to high levels of high molecular weight hyaluronic acid (HMW-HA), a substance ...
- Are millions aging faster because of hidden vitamin B12 deficiency? New Cornell University research links low B12 to muscle weakness and metabolic declineVitamin B12 and healthy aging are now linked by striking new evidence from Cornell University. A landmark study published in the Journal of...
- Tooth regeneration therapy enters first human clinical trials in JapanA groundbreaking human trial in Japan is exploring a revolutionary treatment to regrow teeth. Researchers have identified a way to activate...
- In 1956, Wilson Greatbatch Made a Simple Wiring Mistake at His Workbench: That Unexpected Pulse Led to the Modern PacemakerA chance mistake in 1956 by Wilson Greatbatch led to a groundbreaking discovery. He accidentally created a consistent electrical signal res...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe markets should be in a happy frame of mind till the time the current ceasefire in the Gulf region holds. Not many may like us using the...
- Revised rules for biosimilar drugs enter the final stretchThe Indian government is refining biosimilar drug regulations, aligning with global standards to ensure stringent quality in research and m...
- Rabbits may soon be spared from clinical tests in IndiaThe Central Drugs Standard Control Organisation (CDSCO) has constituted a committee to give recommendations for necessary action in the mat...
- New drug regulatory norms on cardsRevamped policy to help drug cos become inventors and not copiers of MNC brands.
- New drug regulatory norms on cardsRevamped policy to help drug cos become inventors and not copiers of MNC brands.
- Pharma to get new regulatory regimeDrug makers in the country will get a new regulatory regime that is more friendly for investing heavily into high-risk research, testing ex...
Load More
